Kashima Laboratory, Nonclinical Research Center, LSI Medience Corporation, Ibaraki, Japan.
Kumamoto Laboratory, Nonclinical Research Center, LSI Medience Corporation, Kumamoto, Japan.
J Appl Toxicol. 2021 Aug;41(8):1304-1315. doi: 10.1002/jat.4118. Epub 2020 Dec 6.
Itai-itai (Japanese, "It hurts! It hurts!") disease (IID), a form of osteomalacia, can be induced in ovariectomized rats by long-term administration of cadmium (Cd). This IID rat model shows severe anemia, severe nephropathy, and osteomalacia accompanied by iron (Fe) deposition at the mineralization front. We characterized the pathogenesis of Cd-induced bone lesions by investigating the relationship between Fe deposition and osteoid tissue formation in ovariectomized rats. The rats were injected with CdCl (0.5 mg/kg) for 70 weeks, with or without co-injection of erythropoietin (EPO) for varying lengths of time to elucidate whether EPO prevents and/or cures anemia, and, with the restoration from anemia, lessens the osteoid tissue formation. Necropsies were performed at 25, 50, or 70 weeks. Fe deposition at the mineralization front of bone was found at 50 weeks and increased thereafter. Animals injected with EPO showed decreased Fe deposition, although there was no relation between EPO administration and osteoid formation in the femur. Because the increase in bone lesion severity was independent of the amount of Fe deposition, we suggest that Fe deposition is not involved in the etiology of Cd-induced femoral bone lesions.
痛痛病(日语:“痛痛病”),一种佝偻病,可通过长期给予镉(Cd)诱发去卵巢大鼠。这种 IID 大鼠模型表现出严重的贫血、严重的肾病和佝偻病,伴随着矿化前沿的铁(Fe)沉积。我们通过研究铁沉积与去卵巢大鼠类骨质组织形成之间的关系,来描述 Cd 诱导的骨病变的发病机制。将 CdCl 注射到大鼠体内(0.5mg/kg)70 周,或与促红细胞生成素(EPO)共注射不同时间,以阐明 EPO 是否预防和/或治疗贫血,以及从贫血恢复后,是否减少类骨质组织的形成。在 25、50 或 70 周进行尸检。在 50 周时发现骨矿化前沿的铁沉积,并在此后增加。注射 EPO 的动物表现出铁沉积减少,尽管 EPO 给药与股骨类骨质形成之间没有关系。由于骨损伤严重程度的增加与铁沉积量无关,因此我们认为铁沉积不参与 Cd 诱导的股骨骨损伤的病因。